Stroke Package MRI MRA Brain & Carotids at Chughtai Lab

Stroke Package (MRI Brain, MRA Brain and MRA Carotids) With Contrast at Chughtai Lab

The Stroke Package (MRI Brain, MRA Brain, and MRA Carotids) with Contrast at Chughtai Lab is a comprehensive, state-of-the-art neurovascular diagnostic protocol designed to evaluate the structural integrity of the brain parenchyma and the patency of the blood vessels supplying the head and neck. This advanced imaging package combines Magnetic Resonance Imaging (MRI) of the brain with Magnetic Resonance Angiography (MRA) of both the intracranial and extracranial circulation. By utilizing high-field magnetic resonance technology and a gadolinium-based contrast agent, this examination provides highly detailed, multiplanar images without exposing the patient to ionizing radiation. It serves as a critical clinical tool for the early detection, characterization, and management of cerebrovascular diseases, acute ischemic events, and structural abnormalities of the central nervous system.

Magnetic Resonance Imaging (MRI) works by utilizing strong magnetic fields and radiofrequency pulses to temporarily realign hydrogen atoms in the body. As these atoms return to their normal state, they emit signals that are captured by specialized receiver coils and processed by advanced computer algorithms to construct high-resolution cross-sectional images. Magnetic Resonance Angiography (MRA) is a specialized application of MRI that focuses specifically on blood vessels. While some MRA sequences can be performed without contrast using flow-sensitive techniques like Time-of-Flight (TOF), the addition of an intravenous gadolinium-based contrast agent significantly enhances the visualization of vascular anatomy, allowing for the precise identification of slow flow, small vessel pathology, and subtle perfusion abnormalities. This comprehensive evaluation is essential for assessing the carotid and vertebral arteries in the neck, as well as the Circle of Willis and its branches within the brain.

The clinical importance of this package cannot be overstated. Stroke remains a leading cause of mortality and long-term disability worldwide, including in Pakistan. Rapid and accurate diagnosis is paramount to initiating timely therapeutic interventions, such as thrombolysis or endovascular thrombectomy, and to implementing effective secondary prevention strategies. This imaging protocol evaluates critical anatomical structures, including the cerebral cortex, subcortical white matter, basal ganglia, brainstem, cerebellum, internal carotid arteries, external carotid arteries, vertebral arteries, and basilar artery. The diagnostic value of combining MRI and MRA with contrast lies in its ability to differentiate between ischemic and hemorrhagic strokes, identify areas of salvageable brain tissue (ischemic penumbra), locate the site of vascular occlusion or stenosis, and detect underlying predisposing factors such as aneurysms, arteriovenous malformations, or carotid plaque rupture.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure safety, minimize motion artifacts, and obtain the highest quality diagnostic images during the Stroke Package examination at Chughtai Lab. Patients must adhere to the following guidelines:

• Fasting Requirements: Because this examination involves the administration of an intravenous gadolinium-based contrast agent, patients are generally advised to fast (avoid solid food and liquids) for 4 to 6 hours prior to the scheduled scan to minimize the risk of nausea or vomiting during contrast injection.
• Kidney Function Testing: Patients, especially those over 60 years of age or with a history of kidney disease, diabetes, or hypertension, must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report. Gadolinium contrast agents are cleared by the kidneys, and adequate renal function must be verified to prevent rare complications like Nephrogenic Systemic Fibrosis (NSF).
• MRI Safety Screening: Patients must complete a comprehensive MRI safety questionnaire. Because of the powerful magnetic field, individuals with cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), cochlear implants, certain metallic aneurysm clips, or metallic foreign bodies in the eyes cannot undergo this procedure.
• Clothing and Personal Items: Patients should wear comfortable, loose-fitting clothing free of metal zippers, snaps, or buttons. All metallic objects, including jewelry, watches, hairpins, eyeglasses, hearing aids, and credit cards, must be removed before entering the MRI suite.
• Medication and Medical History: Patients should continue taking their prescribed daily medications unless instructed otherwise by their physician. It is crucial to inform the clinical staff of any known allergies, particularly previous adverse reactions to contrast media, asthma, or pregnancy.

During the Procedure

The Stroke Package procedure is conducted by certified radiographers and monitored by consultant radiologists at Chughtai Lab, ensuring patient safety and comfort throughout the process:

• Patient Positioning: The patient is asked to lie flat on their back on a padded, motorized MRI table. A specialized head and neck coil, which acts as an antenna to transmit and receive radiofrequency signals, is positioned comfortably over the patient’s head.
• Intravenous Access: A small intravenous (IV) cannula is placed in a vein, typically in the arm or hand, to facilitate the administration of the gadolinium-based contrast agent at the appropriate phase of the imaging sequence.
• Entering the Scanner: The motorized table slowly glides into the bore of the cylindrical MRI scanner. The interior of the scanner is well-lit and ventilated to ensure patient comfort.
• Imaging Sequences and Noise: During the scan, the machine produces loud tapping, thumping, or humming noises as the gradient coils switch on and off. Patients are provided with hearing protection, such as earplugs or headphones, through which they can listen to music or communicate with the technologist.
• Contrast Administration: Mid-way through the examination, the gadolinium contrast agent is injected through the IV line. Patients may experience a temporary cold sensation in their arm or a mild metallic taste in their mouth, which is entirely normal.
• Duration and Cooperation: The entire examination, including MRI Brain, MRA Brain, and MRA Carotids with contrast, typically takes between 45 to 60 minutes. It is absolutely critical for the patient to remain completely still during this time, as even minor movement can blur the images and compromise diagnostic accuracy.
• Monitoring and Communication: The technologist monitors the patient visually through a viewing window and via an intercom system. The patient is also given an emergency squeeze bulb to signal the staff immediately if they experience any discomfort or anxiety.

When is a Stroke Package Performed?

Evaluation of Acute Stroke and Transient Ischemic Attack (TIA)

Physicians urgently request this package when a patient presents with sudden-onset neurological deficits, such as unilateral weakness, facial drooping, speech difficulty, or vision loss. The scan is vital for differentiating between ischemic stroke (caused by a blood clot) and hemorrhagic stroke (caused by a ruptured blood vessel). Advanced diffusion-weighted imaging (DWI) sequences can detect hyperacute ischemic changes within minutes of symptom onset, allowing clinicians to make rapid decisions regarding thrombolytic therapy or mechanical thrombectomy to save salvageable brain tissue.

Assessment of Carotid Artery Stenosis and Occlusive Disease

This examination is indicated for patients who have experienced a transient ischemic attack (TIA) or are suspected of having carotid artery disease due to a carotid bruit heard during a physical exam. By imaging the extracranial carotid arteries using contrast-enhanced MRA, the scan precisely measures the degree of luminal narrowing (stenosis) caused by atherosclerotic plaque. This information is critical for determining whether a patient requires medical management, carotid endarterectomy, or carotid artery stenting to prevent a future catastrophic stroke.

Investigation of Intracranial Aneurysms and Vascular Malformations

The MRA component of this package is highly sensitive in detecting intracranial aneurysms, which are abnormal bulges in the walls of brain arteries that carry a risk of rupture and subarachnoid hemorrhage. It also evaluates for other vascular anomalies, such as arteriovenous malformations (AVMs), dural arteriovenous fistulas, and cavernous malformations. Physicians order this test for patients with chronic headaches, a family history of aneurysms, or cranial nerve palsies to identify these high-risk vascular lesions before they cause life-threatening bleeding.

Unexplained Neurological Deficits and Persistent Headaches

When patients present with progressive, unexplained neurological symptoms—such as chronic dizziness, vertigo, gait instability, cognitive decline, or persistent, atypical headaches—this comprehensive package is performed to rule out underlying structural or vascular pathologies. The contrast-enhanced MRI and MRA can identify slow-growing brain tumors, demyelinating diseases like multiple sclerosis, chronic subdural hematomas, cerebral vasculitis, or venous sinus thrombosis, providing a clear diagnostic pathway for the treating neurologist.

Post-Stroke Monitoring and Surgical Planning

For patients who have previously suffered a stroke or undergone neurovascular interventions (such as aneurysm coiling, carotid stenting, or bypass surgery), this package is utilized for follow-up assessment. It allows radiologists to monitor the patency of reconstructed vessels, evaluate the success of surgical interventions, detect any recurrent stenosis or new aneurysmal growth, and assess the long-term structural changes in the brain parenchyma, ensuring optimal ongoing patient management.

What Does a Stroke Package Detect?

The Stroke Package (MRI Brain, MRA Brain, and MRA Carotids) with Contrast is highly sensitive and capable of detecting a wide range of structural, vascular, and inflammatory pathologies, including:

• Acute Ischemic Infarction: Areas of restricted diffusion indicating cellular swelling and acute tissue ischemia.
• Chronic Cerebral Infarcts: Older areas of tissue loss (encephalomalacia) from previous strokes.
• Lacunar Infarctions: Small, deep brain strokes involving the penetrating arteries.
• Intracerebral Hemorrhage: Bleeding within the brain parenchyma.
• Subarachnoid Hemorrhage: Bleeding in the space surrounding the brain, often due to aneurysm rupture.
• Subdural and Epidural Hematomas: Blood collections between the brain surface and the skull.
• Carotid Artery Stenosis: Narrowing of the common or internal carotid arteries due to atherosclerotic plaque.
• Carotid Artery Occlusion: Complete blockage of the carotid arteries.
• Vertebral Artery Dissection: A tear in the inner lining of the vertebral artery, a common cause of stroke in young adults.
• Intracranial Aneurysms: Focal dilations of the cerebral arteries, particularly within the Circle of Willis.
• Arteriovenous Malformations (AVMs): Abnormal tangles of blood vessels connecting arteries and veins.
• Cerebral Venous Sinus Thrombosis: Blood clots within the venous drainage pathways of the brain.
• Cerebral Amyloid Angiopathy: Protein deposits in brain blood vessels that increase hemorrhage risk.
• Microvascular Ischemic Disease: Chronic changes in small blood vessels, often linked to aging, hypertension, or diabetes.
• Brain Tumors: Primary neoplasms (e.g., gliomas, meningiomas) or metastatic lesions, highlighted by contrast enhancement.
• Multiple Sclerosis (MS) Plaques: Areas of demyelination in the white matter, showing active inflammation with contrast.
• Cerebral Vasculitis: Inflammation of the blood vessel walls causing luminal irregularities.
• Moyamoya Disease: A rare, progressive cerebrovascular disorder characterized by stenosis of the internal carotid arteries.
• Fibromuscular Dysplasia (FMD): Non-inflammatory vascular disease causing a “string of beads” appearance in arteries.
• Encephalitis or Meningitis: Inflammatory or infectious processes affecting the brain tissue or meninges.
• Brain Abscesses: Localized infections showing ring-enhancing lesions on contrast-enhanced scans.
• Cerebral Atrophy: Generalized or focal loss of brain volume, associated with cognitive decline or neurodegenerative disorders.
• Hydrocephalus: Abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles.
• Wallerian Degeneration: Degenerative changes along injured nerve fiber pathways.
• Developmental Venous Anomalies (DVAs): Benign, congenital variations in venous drainage.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, accurate, and highly reliable diagnostic reporting. For complex imaging studies like the Stroke Package, which requires meticulous evaluation of multiple imaging sequences and vascular reconstructions, the standard turnaround time for the final report is typically within 24 to 48 hours. In urgent or emergency clinical scenarios, preliminary findings can be communicated to the referring physician much faster to facilitate immediate medical decision-making.

Once the report is finalized and signed off by a qualified Consultant Radiologist, patients receive an automated SMS notification. Reports and high-resolution digital images can be accessed conveniently online through the Chughtai Lab Patient Portal or the official Chughtai Lab Mobile App. Patients can also collect physical copies of their reports and high-quality laser-printed films from any main Chughtai Lab diagnostic center. This seamless digital access ensures that patients and their healthcare providers can review the findings promptly, facilitating timely clinical consultation and treatment planning.

Stroke Package Findings Overview

The following table provides an overview of the anatomical structures and vascular parameters evaluated during the Stroke Package, along with typical normal and abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Brain Parenchyma	Normal gray-white matter differentiation; no areas of restricted diffusion, hemorrhage, or abnormal mass effect.	Acute ischemic infarct, intracerebral hemorrhage, demyelinating plaques, primary or metastatic tumors, abscesses.
Extracranial Carotid Arteries	Smooth vessel walls, symmetric caliber, and normal patent lumens without significant stenosis or plaque formation.	Atherosclerotic plaque, severe stenosis, complete occlusion, arterial dissection, fibromuscular dysplasia.
Intracranial Arteries (Circle of Willis)	Symmetric flow signals, normal anatomical branching, and absence of focal dilations or vascular narrowing.	Saccular or fusiform aneurysms, arterial spasm, vessel cut-off indicating acute embolus, arteriovenous malformations.
Vertebrobasilar System	Patent bilateral vertebral arteries and basilar artery with normal anterograde flow.	Vertebral artery hypoplasia, stenosis, basilar artery thrombosis, dolichoectasia (elongation and distension).
Ventricles and CSF Spaces	Normal size, shape, and configuration of the lateral, third, and fourth ventricles; symmetric sulci.	Ventriculomegaly (hydrocephalus), mass effect with midline shift, effacement of sulci due to cerebral edema.
Meninges	No abnormal dural or leptomeningeal thickening or contrast enhancement.	Meningeal enhancement indicating meningitis, dural metastases, or intracranial hypotension.
Cerebral Venous Drainage	Normal patent dural venous sinuses (superior sagittal, transverse, sigmoid sinuses) with regular flow voids.	Dural venous sinus thrombosis, venous congestion, cortical venous thrombosis.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Stroke Package?

• Experienced Healthcare Professionals: Your scans are interpreted by highly qualified Consultant Radiologists specializing in neuroradiology, ensuring precise and accurate diagnostic reports.
• Patient-Focused Care: Chughtai Lab prioritizes patient comfort and safety, providing a supportive environment and clear guidance throughout the imaging procedure.
• Quality Diagnostic Services: Operating under stringent international quality control standards, Chughtai Lab ensures high-fidelity imaging and reliable results.
• Professional Reporting: Detailed, structured reports are generated with high-resolution vascular reconstructions, providing clear answers to your referring physician.
• Modern Diagnostic Approach: Utilizing advanced high-field MRI scanners and specialized coil systems to capture high-resolution images of the brain and blood vessels.
• Comfortable Environment: The imaging suites are designed to minimize patient anxiety, featuring modern ventilation, lighting, and communication systems.
• Convenient Location: With an extensive network of diagnostic centers across Pakistan, accessing high-quality MRI and MRA services is convenient and accessible.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to delivering timely and precise diagnostic insights, crucial for the effective management of stroke and vascular disorders.